ID: ALA4586506

Max Phase: Preclinical

Molecular Formula: C21H17F3N4O

Molecular Weight: 398.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CNc2nn(-c3cccnc3)c3ccc(C(F)(F)F)cc23)cc1

Standard InChI:  InChI=1S/C21H17F3N4O/c1-29-17-7-4-14(5-8-17)12-26-20-18-11-15(21(22,23)24)6-9-19(18)28(27-20)16-3-2-10-25-13-16/h2-11,13H,12H2,1H3,(H,26,27)

Standard InChI Key:  DZGCWNQRWOUSDZ-UHFFFAOYSA-N

Associated Targets(Human)

Phosphodiesterase 2A 1799 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phosphodiesterase 5A 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.39Molecular Weight (Monoisotopic): 398.1354AlogP: 5.06#Rotatable Bonds: 5
Polar Surface Area: 51.97Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.88CX LogP: 4.37CX LogD: 4.37
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.43

References

1. Bollenbach M, Lugnier C, Kremer M, Salvat E, Megat S, Bihel F, Bourguignon JJ, Barrot M, Schmitt M..  (2019)  Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model.,  177  [PMID:31158744] [10.1016/j.ejmech.2019.05.026]

Source